Healthcare IT firm QuadraMed has been sold to San Francisco-based Francisco Partners, a technology-focused private equity firm, the company said.
As a result of the acquisition, QuadraMed's common stockholders are entitled to receive $8.50 for each share of common stock they own; the company's Series A Preferred Stockholders are entitled to receive $13.71 for each share of QuadraMed's Series A Preferred Stock they own. In addition, QuadraMed's common stock will no longer be listed for trading on the Nasdaq Global Market, according to the Reston, VA-based company.
Related Reading
QuadraMed, e-MDs to collaborate, January 12, 2010
QuadraMed releases new HIM package, December 17, 2009
QuadraMed to be bought by private equity firm, December 10, 2009
QuadraMed taps McKesson vet as VP, December 4, 2009
QuadraMed posts lower Q3 sales, November 6, 2009
Copyright © 2010 AuntMinnie.com